Merit Medical Q4 revenue $393.9M (+11% YoY); guides FY2026 EPS $4.01-$4.15

MERIT MEDICAL SYSTEMS INC

2025-FY EPS reported $2.13 revenue$1,515,906,000

Q4 revenue $393.9M (+11% YoY); GAAP EPS $0.63 (+37%); Non-GAAP EPS $1.04 (+12%).
FY2025 revenue $1.516B (+12% YoY); GAAP EPS $2.13 (+5%); Non-GAAP EPS $3.83 (+11%).
Q4 Non-GAAP operating margin 21.0% vs 19.6% prior year; Free cash flow $74.0M (+13%).
FY2026 guidance: revenue $1.610-$1.630B (+6-8%); Non-GAAP EPS $4.01-$4.15 (+5-8%).
Constant currency organic revenue grew 7% in both Q4 and FY2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.